Open Access
Performance standards for antimicrobial susceptibility testing
Reads0
Chats0
TLDR
The supplemental information presented in this document is intended for use with the antimicrobial susceptibility testing procedures published in the following Clinical and Laboratory Standards Institute (CLSI)–approved standards.Abstract:
The supplemental information presented in this document is intended for use with the antimicrobial susceptibility testing procedures published in the following Clinical and Laboratory Standards Institute (CLSI)–approved standards: M02-A12—Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Twelfth Edition; M07-A10—Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Tenth Edition; and M11-A8—Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard— Eighth Edition. The standards contain information about both disk (M02) and dilution (M07 and M11) test procedures for aerobic and anaerobic bacteria. Clinicians depend heavily on information from the microbiology laboratory for treatment of their seriously ill patients. The clinical importance of antimicrobial susceptibility test results demands that these tests be performed under optimal conditions and that laboratories have the capability to provide results for the newest antimicrobial agents. The tabular information presented here represents the most current information for drug selection, interpretation, and QC using the procedures standardized in the most current editions of M02, M07, and M11. Users should replace the tables published earlier with these new tables. (Changes in the tables since the previous edition appear in boldface type.) Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing. 26th ed. CLSI supplement M100S (ISBN 1-56238-923-8 [Print]; ISBN 1-56238924-6 [Electronic]). Clinical and Laboratory Standards Institute, 950 West Valley Road, Suite 2500, Wayne, Pennsylvania 19087 USA, 2016. The data in the interpretive tables in this supplement are valid only if the methodologies in M02-A12—Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard—Twelfth Edition; M07-A10—Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard—Tenth Edition; and M11-A8—Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria; Approved Standard— Eighth Edition are followed.read more
Citations
More filters
Journal ArticleDOI
Staphylococcus aureus Isolated From Retail Meat and Meat Products in China: Incidence, Antibiotic Resistance and Genetic Diversity
Shi Wu,Jiahui Huang,Qingping Wu,Jumei Zhang,Feng Zhang,Xiaojuan Yang,Haoming Wu,Haiyan Zeng,Moutong Chen,Yu Ding,Juan Wang,Tao Lei,Shuhong Zhang,Liang Xue +13 more
TL;DR: The high antibiotic resistance is alarming and raising public health concern in China, and S. aureus was readily detected in Chinese retail meat and meat products but the level were not very excessive.
Journal ArticleDOI
Risk factors for community-acquired urinary tract infection caused by ESBL-producing bacteria in children
Ozgur Kizilca,Rengin Şiraneci,Alev Yilmaz,Alev Yilmaz,Nevin Hatipoğlu,Erkut Öztürk,Aysel Kiyak,Dilek Ozkok +7 more
TL;DR: The aim of the present study was to investigate the risk factors of antimicrobial resistance in children with urinary tract infection caused by extended‐spectrum beta‐lactamase (ESBL)‐producing bacteria.
Journal ArticleDOI
Decline in Pneumococcal Nasopharyngeal Carriage of Vaccine Serotypes After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Children in Atlanta, Georgia.
Ankita Patel Desai,Dolly Sharma,Emily K. Crispell,Wendy Baughman,Stepy Thomas,Amy Tunali,Logan K. Sherwood,April Zmitrovich,Robert C. Jerris,Sarah W. Satola,Bernard Beall,Matthew R. Moore,Shabnam Jain,Monica M. Farley +13 more
TL;DR: Introduction of PCV13 for universal infant use was associated with significant reductions in nasopharyngeal carriage of PCv13 serotypes and resistant strains, with a similar decline in penicillin nonsusceptibility.
Journal ArticleDOI
Risk Factors for Death among Children Less than 5 Years Old Hospitalized with Diarrhea in Rural Western Kenya, 2005–2007: A Cohort Study
Ciara E. O’Reilly,Peter Jaron,Benjamin Ochieng,Amek Nyaguara,Jacqueline E. Tate,Michele B. Parsons,Cheryl A. Bopp,Kara A. Williams,Jan Vinjé,Elizabeth Blanton,Kathleen Wannemuehler,John M. Vulule,Kayla F. Laserson,Robert F. Breiman,Daniel R. Feikin,Marc-Alain Widdowson,Eric D. Mintz +16 more
TL;DR: A hospital-based surveillance study conducted by Ciara O'Reilly and colleagues describes the risk factors for death amongst children who have been hospitalized with diarrhea in rural Kenya.
Journal ArticleDOI
Drug Combinations against Borrelia burgdorferi Persisters In Vitro: Eradication Achieved by Using Daptomycin, Cefoperazone and Doxycycline
TL;DR: Daptomycin plus doxycycline and cefoperazone eradicated the most resistant microcolony form of B. burgdorferi persisters and did not yield viable spirochetes upon subculturing, suggesting durable killing that was not achieved by any other two or three drug combinations.